PT Bundamedik Tbk (IDX:BMHS)

PT Bundamedik Tbk Cash Flow Statement

Financials in millions IDR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Net Income	12,419	11,944	7,461	83,228	214,489
Depreciation & Amortization	-	119,729	125,821	120,221	85,127
Other Operating Activities	238,203	-97,693	-81,843	-72,364	49,822
Operating Cash Flow	250,622	33,979	51,439	131,084	349,438
Operating Cash Flow Growth	637.57%	-33.94%	-60.76%	-62.49%	83.57%
Capital Expenditures	-218,905	-236,025	-209,353	-301,730	-298,175
Sale of Property, Plant & Equipment	1,493	1,015	1,638	24.79	-
Sale (Purchase) of Real Estate	-	-10,282	-	-	-
Investment in Securities	-	-	-4,506	-136,329	-21,495
Investing Cash Flow	-217,412	-245,291	-212,222	-438,034	-319,670
Short-Term Debt Issued	-	-	-	-	7,246
Long-Term Debt Issued	178,622	492,138	1,152,656	297,955	143,796
Total Debt Issued	178,622	492,138	1,152,656	297,955	151,042
Long-Term Debt Repaid	-152,578	-452,388	-976,306	-56,291	-177,811
Total Debt Repaid	-152,578	-452,388	-976,306	-56,291	-177,811
Net Debt Issued (Repaid)	26,045	39,750	176,351	241,664	-26,769
Issuance of Common Stock	-	-	-	-	226,089
Common Dividends Paid	-16,403	-4,818	-12,905	-22,000	-19,500
Other Financing Activities	401.31	337,654	-9,882	-113,198	-21,352
Financing Cash Flow	10,043	372,586	153,563	106,466	158,468
Net Cash Flow	43,253	161,274	-7,220	-200,483	188,236
Free Cash Flow	31,716	-202,046	-157,915	-170,646	51,263
Free Cash Flow Growth	-	-	-	-	-63.58%
Free Cash Flow Margin	1.97%	-13.00%	-10.61%	-10.29%	2.71%
Free Cash Flow Per Share	3.58	-23.48	-18.36	-19.84	5.96
Cash Interest Paid	-	60,189	49,569	37,967	16,086
Cash Income Tax Paid	-	17,812	28,055	102,316	34,489
Levered Free Cash Flow	-160,208	-196,509	-85,632	-167,072	19,609
Unlevered Free Cash Flow	-118,004	-156,070	-52,325	-140,388	32,128

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.